- Home
- EVMN vs BFST Comparison
EVMN vs BFST Comparison
Compare EVMN & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | BFST |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.4M | 883.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | EVMN | BFST |
|---|---|---|
| Price | $23.51 | $27.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $43.29 | $32.75 |
| AVG Volume (30 Days) | ★ 234.8K | 129.1K |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ 23.45 |
| EPS | N/A | ★ 2.79 |
| Revenue | N/A | ★ $10,704,000.00 |
| Revenue This Year | N/A | $22.53 |
| Revenue Next Year | N/A | $4.86 |
| P/E Ratio | ★ N/A | $9.87 |
| Revenue Growth | N/A | ★ 1.20 |
| 52 Week Low | $13.89 | $20.93 |
| 52 Week High | $33.20 | $30.32 |
Technical Indicators
Market Signals| Indicator | EVMN | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 50.75 | 56.67 |
| Support Level | $21.14 | $25.56 |
| Resistance Level | $25.50 | $28.65 |
| Average True Range (ATR) | 1.97 | 0.55 |
| MACD | -0.05 | 0.18 |
| Stochastic Oscillator | 63.38 | 95.36 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.